If you liked this article you might like

XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO
Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk
Nektar Addiction-Resistant Opioid Reduces Chronic Pain in Late-Stage Study